CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 160 filers reported holding CARDLYTICS INC in Q1 2022. The put-call ratio across all filers is 3.56 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,503,689 | +161.1% | 454,769 | 0.0% | 5.27% | +124.6% |
Q2 2023 | $2,874,140 | +86.2% | 454,769 | 0.0% | 2.35% | +234.7% |
Q1 2023 | $1,543,941 | -41.3% | 454,769 | 0.0% | 0.70% | -37.0% |
Q4 2022 | $2,628,565 | -38.5% | 454,769 | 0.0% | 1.11% | -63.8% |
Q3 2022 | $4,275,000 | -64.9% | 454,769 | -16.7% | 3.08% | -59.7% |
Q2 2022 | $12,184,000 | -59.4% | 546,131 | 0.0% | 7.64% | -39.5% |
Q1 2022 | $30,026,000 | -16.8% | 546,131 | 0.0% | 12.62% | -12.6% |
Q4 2021 | $36,094,000 | +7.4% | 546,131 | +36.3% | 14.44% | +0.3% |
Q3 2021 | $33,622,000 | -17.1% | 400,545 | +25.4% | 14.40% | -0.9% |
Q2 2021 | $40,534,000 | +44.0% | 319,345 | +24.5% | 14.53% | +24.7% |
Q1 2021 | $28,149,000 | -34.9% | 256,600 | -15.2% | 11.66% | -33.7% |
Q4 2020 | $43,216,000 | +44.5% | 302,700 | -28.6% | 17.58% | +24.4% |
Q3 2020 | $29,908,000 | -2.9% | 423,800 | -3.7% | 14.12% | -10.1% |
Q2 2020 | $30,798,000 | +100.2% | 440,100 | 0.0% | 15.71% | +32.6% |
Q1 2020 | $15,386,000 | -10.3% | 440,100 | +61.3% | 11.84% | -8.7% |
Q4 2019 | $17,154,000 | – | 272,900 | – | 12.97% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAS Investment Partners, LLC | 4,488,972 | $640,891,000 | 35.51% |
Antipodean Advisors LLC | 656,000 | $93,657,000 | 26.30% |
KPS Global Asset Management UK Ltd | 1,021,830 | $145,887,000 | 21.39% |
BRIGHTLIGHT CAPITAL MANAGEMENT LP | 302,700 | $43,216,000 | 17.58% |
Oakcliff Capital Partners, LP | 269,895 | $38,533,000 | 15.30% |
Alua Capital Management LP | 920,259 | $131,385,000 | 9.19% |
Covey Capital Advisors, LLC | 47,736 | $6,815,000 | 5.95% |
EVR Research LP | 50,000 | $7,139,000 | 5.83% |
683 Capital Management, LLC | 659,997 | $94,228,000 | 4.46% |
Hidden Lake Asset Management LP | 72,900 | $10,408,000 | 4.08% |